Short answer: Semax is unusual among research peptides because it is a registered medicine in Russia, used there as nasal drops in neurology, mainly after stroke. That gives it decades of real-world clinical use. The side effects described are generally mild: nasal irritation, headache, and feeling overstimulated or irritable in some people. The catch is that most of the clinical evidence comes from Russian studies that Western reviewers rate as variable in quality, and it has never been approved by the FDA or Health Canada. Here is what is known, and what is not.
What Semax is
Semax is a synthetic seven-amino-acid peptide (Met-Glu-His-Phe-Pro-Gly-Pro) developed in the 1980s at the Institute of Molecular Genetics in Moscow. It is based on ACTH(4-10), a fragment of the stress hormone ACTH, with a Pro-Gly-Pro tail added to slow its breakdown. Importantly, the fragment does not stimulate cortisol release the way full ACTH does. In animal studies, Semax raised levels of BDNF, a growth factor for nerve cells, which is the main basis for interest in it for stroke recovery and cognition. For how it compares with its sister peptide, see Selank vs Semax.
The clinical evidence and its limits
| What exists | What it shows | Limits |
|---|---|---|
| Registration as a medicine in Russia | Decades of clinical use as nasal drops in neurology | Registration standards differ from FDA or Health Canada review |
| Russian stroke studies | Reports of better neurological recovery | Mostly small, often open-label; quality varies |
| Western randomized trials | Essentially none | No independent confirmation |
| Long-term safety studies | None published in English | Unknown |
So Semax sits between the two extremes: much more human use than most research peptides, much less independent evidence than an approved drug.
Side effects reported
| Effect | How often | Notes |
|---|---|---|
| Nasal irritation, stinging, dryness | Most commonly mentioned | Linked to the intranasal route. |
| Headache | Occasional | Often reported early in use. |
| Overstimulation, irritability, anxiety | Occasional, in sensitive people | Consistent with its stimulating profile. |
| Trouble sleeping | Occasional | Users often report this when taken late in the day. |
| Hair shedding | Anecdotal | Forum reports only; no study supports it. |
Frequencies here are qualitative: Russian clinical sources describe side effects as rare and mild, but they do not report rates in a way that can be compared with Western trials.
Who should be careful
- People on antidepressants or stimulants. Because Semax affects dopamine and serotonin signalling in animal studies, combining it with SSRIs, MAOIs or stimulant medications is flagged as a concern. Interactions have not been studied.
- People with anxiety or bipolar disorder. Overstimulation is the most consistent complaint.
- Pregnancy. No data.
Health Canada, FDA and sport
| Health Canada | Not authorized. Semax was among products seized from Canada Peptide in 2025. |
|---|---|
| FDA (USA) | Not approved. In July 2026 an FDA advisory committee recommended allowing pharmacy compounding of Semax; the vote is non-binding and is not an approval. |
| Sport | Not approved for human use, so athletes in tested sport should treat it as prohibited under WADA’s non-approved substances rule. |
See TrueLabs Semax and its COA →
Frequently asked questions
Cliquez sur une question pour afficher la réponse.
What are the side effects of Semax?
The most commonly described side effects are nasal irritation, headache, overstimulation or irritability, and trouble sleeping. Russian clinical sources describe them as rare and mild, but rates have not been measured in Western trials.
Is Semax safe?
It has decades of clinical use in Russia with mostly mild reported effects, but no independent Western randomized trials or long-term safety studies have been published.
Is Semax approved anywhere?
It is registered as a medicine in Russia. It is not approved by the FDA or Health Canada.
Can Semax cause anxiety?
Overstimulation and irritability are reported in some people, especially those prone to anxiety. This is anecdotal and has not been measured.
Does Semax raise cortisol?
Semax is built from an ACTH fragment that does not stimulate cortisol release the way full ACTH does.
Is Semax legal in Canada?
Semax is not authorized by Health Canada and was among the unauthorized products seized from Canada Peptide in 2025.
Related reading
- Selank vs Semax: same lab, two very different peptides
- The Selank mistakes almost everyone makes
- How to store peptides
References
- PubMed search: Semax clinical and preclinical literature. PubMed
- Dolotov OV, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006. PubMed
- Health Canada. Advisory RA-77807 (Canada Peptide), August 1, 2025. Recalls and Safety Alerts
- NPR. FDA panel considers easing peptide restrictions. July 23, 2026. NPR
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing in this article is medical advice. If you take antidepressants or stimulant medication, talk to a doctor or pharmacist.